Skip to main content
. Author manuscript; available in PMC: 2022 Jan 3.
Published in final edited form as: Cancer Res. 2019 Dec 10;80(4):857–867. doi: 10.1158/0008-5472.CAN-19-1991

Table 2.

Occurrence of functionally characterized missense alleles in patient and control populations

Discovery Cohorts (n=3,359) Clinical Cohort EXAC (n=60,327) FLOSSIES (n=9,884)
Breast Cancer (n=101,759) Ovarian Cancer (n=15,587)
Wildtypes S407G 1 1 -- -- --
H587L 1 2 -- -- --
Q740H 5 163 32 56 8
A745T 2 18 2 8 1
L844Ib -- -- -- -- --
Hypomorphs P47Aa 4 96 11 29 5
E511G 1 1 -- -- --
E636K 1 -- -- -- --
I691L 2 13 2 -- --
G649Sb -- -- -- -- --
I782V 1 10 1 2 1
D791V 1 -- -- -- --
K797R 1 3 4 -- 1
Y822H 1 1 -- 1 --
Nulls A349Pa 1 7 2 3 --
V676E 1 -- -- -- --
G690E 1 1 -- -- --
R777C 1 1 -- -- --
C832Yb -- -- -- -- --
R865W 1 6 2 1 2
a

previously characterized as deleterious missense variant

b

rare missense variants previously reported in ovarian cancer cases(14)